Jeffrey Edwards, Arnold Pinkston, Gregory Hinckley

Bio-Rad has elected three new board members — Jeffrey Edwards, Gregory Hinckley, and Arnold Pinkston — at its annual shareholders meeting.

Jeffrey Edwards previously served as CEO of Allergan from 2005 to August 2014, and retired from the company in 2015 after 22 years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.